Review Article

Gene Regulation Systems for Gene Therapy Applications in the Central Nervous System

Table 1

Summary of use of gene regulation systems for in vivo CNS applications.

Regulation system (VC*)Stimuli/doseDelivery vehicleSpeciesTransgeneComments [ref]

Tet-Off (VC1)Dox (300 μg/mL and 2 mg/mL)AAVRatGFPSome leakiness. No further transgene repression by increasing dox dosage [4].

Tet-On (VC2)Dox (6 g/kg)AAVRatEGFPNo repression or basal expression data [5].

Tet-On (VC1 & 2)Dox (2 mg/mL)AdRatLacZNegligible expression following dox removal [6].

Tet-Off (VC1)DoxAAVRatGDNFUndetectable transgene levels at serum dox levels below those required for antimicrobial activity [7].

Tet-Off (VC2)Dox (300 μg/mL)AAVRatEGFPLow basal expression with addition of insulator sequences [9].

Tet-On (VC2)Dox (600 μg/mL)AAVRatGDNFSome basal expression [11].

Tet-Off (VC3)Dox (2 mg/mL)AdRatCaspase-9 & EGFPVariable repression achieved; transgene dependent [13].

Tet-On (VC1)Dox (2 mg/mL)LVRatLuciferaseLow basal expression [19].

RapamycinRapamycin (10 mg/kg)AAVRathAADCRobust phenotypic response in 6-OHDA model. Low basal expression without phenotypic effect [25].

RapamycinAP21967 (1 mL/kg)LVMouseGFP & GDNFNo basal expression [28].

RU486RU486 (25 mg/kg)HSVRatLacZVery low basal expression [31].

HRE30 min hypoxia in a 3% O2 hypoxic chamberAdMouseLuciferaseNo transgene expression under normoxic conditions [36].

HRE60 min MCAOAdMouseBDNF & EGFPNeuroprotection & phenotypic changes seen. No comparison with unregulated transgene expression [37].

HRE45 min MCAOAAVMouseVEGF or LacZAngiogenesis seen. No transgene expression under nonischemic conditions [39].

HRESpinal cord contusion injuryNaked plasmid injectionRatVEGFLocomotor recovery compared to uninjected controls [42].

HRESpinal cord contusion injuryNaked plasmid injectionRatLuciferaseHigher transgene expression in injured compared to normal spinal cord [44].

HRESpinal cord contusion injuryEx vivo stem cell therapyRatLuciferaseLow transgene expression in normal spinal cord [45].

*VC, Vector Configuration (see Figure 2); Dox, doxycycline; GFP, Green Fluorescent Protein; EGFP, Enhanced Green Fluorescent Protein.